The effect of PCO2 on hypoxic pulmonary vasoconstriction

Area of Science:

• Physiology
• Pulmonary Medicine
• Anesthesiology

Background:

• Low ventilation/perfusion (V/Q) ratio in lung areas causes hypoxemia.
• Hypoxic pulmonary vasoconstriction (HPV) is a mechanism to correct low V/Q by reducing blood flow to hypoxic lung areas.
• Carbon dioxide levels influence the HPV response.

Purpose of the Study:

• To investigate the relationship between carbon dioxide levels and HPV in hypoxic lung areas.
• To determine the effect of altering PaCO2 on HPV and PaO2 in anesthetized dogs.
• To identify the specific role of alveolar CO2 concentration in modulating HPV.

Main Methods:

• Used a tracheal divider in anesthetized dogs to ventilate lung areas separately with hypoxic (nitrogen) and oxygenated (100% oxygen) air.
• Assessed relative lung perfusion using 133Xe exhalation after intravenous infusion.
• Manipulated PaCO2 by altering ventilation and inspired CO2 (PICO2) levels in different lung areas.

Main Results:

• Increasing PaCO2 enhanced HPV and PaO2.
• HPV was abolished and PaO2 decreased when PaCO2 dropped to 3.3 kPa.
• Altering inspired CO2 (PICO2) to the hypoxic lung maintained HPV even when overall PaCO2 decreased.
• End-tidal CO2 (PETCO2) in the hypoxic lung was identified as the key factor modulating HPV.

Conclusions:

• Low end-tidal CO2 (PETCO2) in hypoxic lung areas impairs HPV, leading to more severe hypoxemia.
• Increasing hypoxic lung PETCO2 may improve PaO2 in anesthetized and intensive care unit patients by reinforcing HPV.
• The concentration of alveolar CO2 in the hypoxic lung is critical for modifying HPV and oxygenation.